SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

TRAPELLA, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.994
AS - Asia 6.315
EU - Europa 5.024
SA - Sud America 987
AF - Africa 101
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 8
Totale 27.440
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.659
SG - Singapore 2.637
CN - Cina 1.837
IT - Italia 1.244
DE - Germania 1.023
BR - Brasile 828
HK - Hong Kong 597
GB - Regno Unito 555
UA - Ucraina 513
FI - Finlandia 413
VN - Vietnam 398
TR - Turchia 358
PL - Polonia 305
SE - Svezia 266
CA - Canada 179
RU - Federazione Russa 179
MX - Messico 122
ID - Indonesia 121
FR - Francia 104
BE - Belgio 100
IN - India 98
JP - Giappone 82
NL - Olanda 75
AR - Argentina 53
ZA - Sudafrica 51
BD - Bangladesh 47
ES - Italia 47
LT - Lituania 44
AT - Austria 40
CZ - Repubblica Ceca 38
IQ - Iraq 25
EC - Ecuador 22
CO - Colombia 17
IE - Irlanda 16
VE - Venezuela 16
IR - Iran 15
CL - Cile 14
PE - Perù 14
NO - Norvegia 13
BG - Bulgaria 12
MA - Marocco 12
KR - Corea 11
PY - Paraguay 11
SA - Arabia Saudita 10
AU - Australia 9
PK - Pakistan 9
UZ - Uzbekistan 9
NP - Nepal 8
DZ - Algeria 7
RO - Romania 7
TN - Tunisia 7
UY - Uruguay 7
DO - Repubblica Dominicana 6
EG - Egitto 6
JM - Giamaica 6
JO - Giordania 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
KZ - Kazakistan 5
TW - Taiwan 5
CH - Svizzera 4
DK - Danimarca 4
EU - Europa 4
HN - Honduras 4
IL - Israele 4
KE - Kenya 4
LV - Lettonia 4
MY - Malesia 4
PA - Panama 4
TH - Thailandia 4
XK - ???statistics.table.value.countryCode.XK??? 4
BO - Bolivia 3
GT - Guatemala 3
KW - Kuwait 3
NG - Nigeria 3
PT - Portogallo 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AO - Angola 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
EE - Estonia 2
ET - Etiopia 2
GR - Grecia 2
KG - Kirghizistan 2
LU - Lussemburgo 2
PH - Filippine 2
RS - Serbia 2
SM - San Marino 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
CV - Capo Verde 1
CY - Cipro 1
DM - Dominica 1
GE - Georgia 1
GI - Gibilterra 1
GY - Guiana 1
Totale 27.428
Salva come PNG Salva come JPEG
Città #
Dallas 1.731
Ashburn 1.546
Singapore 1.545
Fairfield 1.351
Woodbridge 1.219
Ann Arbor 801
Houston 789
Beijing 712
Chandler 672
Santa Clara 617
Hong Kong 589
Seattle 585
Jacksonville 556
Munich 526
Wilmington 524
Cambridge 468
Ferrara 454
Warsaw 296
New York 250
Los Angeles 235
Helsinki 207
Izmir 199
Nanjing 174
Princeton 154
Milan 141
Shanghai 128
Boardman 115
Dong Ket 106
Ho Chi Minh City 104
San Diego 101
Jakarta 98
Brussels 95
London 89
Mexico City 85
São Paulo 83
Turku 78
Bologna 68
Tokyo 67
Dearborn 60
Buffalo 58
Hefei 58
Shenyang 57
Hanoi 56
The Dalles 55
Montreal 53
Nanchang 51
Orem 51
Toronto 51
Chicago 48
Poplar 48
Brooklyn 47
Addison 46
Stockholm 45
Tianjin 45
Bremen 43
Frankfurt am Main 43
Moscow 42
Denver 41
Rio de Janeiro 41
Atlanta 39
Chennai 38
Falls Church 36
Johannesburg 36
Amsterdam 35
Redwood City 35
Jiaxing 33
Rome 33
Hebei 32
Auburn Hills 31
Falkenstein 31
San Jose 31
Boston 30
San Francisco 30
Manchester 29
Mcallen 26
Norwalk 26
Mountain View 25
Phoenix 25
Changsha 24
San Mateo 24
Washington 24
Belo Horizonte 20
Montréal 20
Charlotte 19
Brno 18
Zhengzhou 18
Council Bluffs 17
Curitiba 17
Ferrara di Monte Baldo 17
Jyväskylä 17
Nuremberg 17
Columbus 16
Jinan 16
Olomouc 16
Ottawa 16
Philadelphia 16
Vienna 16
Ankara 15
Des Moines 15
Dublin 15
Totale 19.591
Salva come PNG Salva come JPEG
Nome #
1,3,8-Triazaspiro compounds and their use as medicaments for the treatment of reperfusion injury. 1.037
1,3,8-Triazaspiro[4.5]decane Derivatives Inhibit Permeability Transition Pores through a FO-ATP Synthase c Subunit Glu119-Independent Mechanism That Prevents Oligomycin A-Related Side Effects 952
1‐cyclohexyl‐x‐methoxybenzene derivatives, novel psychoactive substances seized on the internet market. Synthesis and in vivo pharmacological studies in mice 371
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 346
A linear allergic contact dermatitis to p-tert-butylphenol formaldehyde resin sectorially present in a neoprene orthopedic brace: role of spectroscopy 312
1,4-Dithiane-2,5-diol: An Attractive Platform for the Synthesis of Sulfur-Containing Functionalized Heterocycles 297
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 275
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 260
A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism 258
Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair Novel Object Recognition in mice: Behavioral, electrophysiological and neurochemical evidence 254
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 252
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction 248
Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice 245
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 242
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 237
Expeditious Synthesis and Biological Characterization of Enantio-Enriched (-)-Nutlin-3 230
C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasome inhibitors 218
New TRAP1 and Hsp90 chaperone inhibitors with cationic components: Preliminary studies on mitochondrial targeting 216
null 214
Conjugation of LasR Quorum-Sensing Inhibitors with Ciprofloxacin Decreases the Antibiotic Tolerance of P-aeruginosa Clinical Strains 213
Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor 208
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 206
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 206
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 205
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 204
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 203
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 201
HelixComplex snail mucus exhibits pro-survival, proliferative and pro-migration effects on mammalian fibroblasts 201
In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl 199
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 199
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 198
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 196
Nocistatin inhibits 5-hydroxytryptamine release in the mouse neocortex via presynaptic G i/o protein linked pathways 195
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 194
A new synthetic approach to 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-benzimidazol-2-one (J-113397), the first non-peptide ORL-1 receptor antagonist 190
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex 190
Dopamine-nociceptin/orphanin FQ interactions in the substantia nigra reticulata of hemiparkinsonian rats: Involvement of D2/D3 receptors and impact on nigro-thalamic neurons and motor activity 190
Physicochemical stability of cabazitaxel and docetaxel solutions 190
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 189
Sviluppo di un Sistema combinato a filiera controllata per l’allevamento, l’estrazione, la caratterizzazione e la sanificazione del secreto di chiocciola 189
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 185
C subunit of F1/FO-ATP synthase as target for preventing the detrimental effect of myocardial ischemia/reperfusion injury 184
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 183
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 183
Letter to the Editor: Antimicrobial properties of mucus from the brown garden snail Helix aspersa 183
Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides 183
JWH-018 impairs sensorimotor functions in mice 182
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 181
Helix aspersa muller mucus (Helixcomplex ®) interferes with Herpes simplex 1 virus infection 181
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 179
Further studies on lead compounds containing the opioid pharmacophore Dmt-Tic. 178
Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors 177
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 177
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 177
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 175
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 175
Synthesis and activity of isoxazoline vinyl ester pseudopeptides as proteasome inhibitors 173
Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test 173
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 172
Biochemically Controlled Release of Dexamethasone Covalently Bound to PEDOT 172
The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway 170
Neuropeptide S receptor ligands: a patent review (2005-2016) 170
Recent advances in the stereoselective synthesis of trans-3,4- disubstituted-piperidines: applications to (-)paroxetine 169
Neurological, sensorimotor and cardiorespiratory alterations induced by methoxetamine, ketamine and phencyclidine in mice 169
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 169
Structure-activity study at positions 3 and 4 of human neuropeptide S. 168
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 164
P3 and P4 position analysis of vinyl ester pseudopeptide proteasome inhibitors 163
A Convenient Route to Enantiomerically Pure 2-Substituted Methyl Glycerate Derivatives 162
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 161
Synthesis and biological evaluation of new vinyl ester pseudotripeptide proteasome inhibitors 160
Mastering chiral substituted 2-oxopiperazines 160
The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor 160
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein Gαqi5 159
HelixComplex snail mucus as a potential technology against O3 induced skin damage 159
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 158
New opioid designed multiple ligand from Dmt-Tic and morphinan pharmacophores 157
Novel halogenated synthetic cannabinoids impair sensorimotor functions in mice 157
A new amido-phosphine of dichloroacetic acid as an active ligand for metals of pharmaceutical interest. Synthesis, characterization and tests of antiproliferative and pro-apoptotic activity 157
Proteomic approach to the identification of early phase biomarker for anticancer peptides targeting thefolate pathway 156
Pseudomonas aeruginosa quorum sensing molecule N-(3-oxododecanoyl)-L-homoserine-lactone induces HLA-G expression in human immune cells 156
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68). 155
Anxiolytic and antidepressant-like activities of UFP-512, a novel selective delta opiold receptor agonist 153
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): Identification of a partial agonist of the UT receptor 152
NOP receptor pharmacological profile – A dynamic mass redistribution study 150
Development and characterisation of novel fentanyl-delta opioid receptor antagonist based bivalent ligands 149
Enzymatic esterification as potential strategy to enhance the sorbic acid behavior as food and beverage preservative 149
Role of benzimidazole (Bid) in the d-opioid agonist pseudopeptide H-Dmt-Tic-NH-CH2-Bid (UFP-502) 148
Design of Nanosystems for the Delivery of Quorum Sensing Inhibitors: A Preliminary Study 148
Glyceric Prodrug of Ursodeoxycholic Acid (UDCA): Novozym 435-Catalyzed Synthesis of UDCA-Monoglyceride 148
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist 147
6-N,N-dimethylamino-2,3-naphthalimide: A new environment-sensitive fluorescent probe in delta- and mu-selective opioid peptides 145
Neuropeptide S inhibits release of 5-HT and glycine in mouse amygdala and frontal/prefrontal cortex through activation of the neuropeptide S receptor 145
Helix aspersa muller mucus (Helixcomplex ®) p41 protein prevents Pseudomonas aeruginosa growth and promotes mammalian bronchial epithelial cell proliferation 145
A Cationic Contrast Agent in X-ray Imaging of Articular Cartilage: Pre-Clinical Evaluation of Diffusion and Attenuation Properties 144
Chemoenzymatic Stereodivergent Synthesis of All the Possible Stereoisomers of the 2,3-Dimethylglyceric Acid Ethyl Ester 144
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 141
JWH-018 and its N-pentyl-halogenated derivates impair sensory motor functions in mice. 139
Xylitol as a Hydrophilization Moiety for a Biocatalytically Synthesized Ibuprofen Prodrug 136
NOP agonist action of cebranopadol counteracts its liability to promote physical dependence 135
Totale 20.380
Salva come PNG Salva come JPEG
Categoria #
all - tutte 124.251
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 589
Totale 124.840
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.717 0 0 0 0 0 204 169 304 116 400 284 240
2021/20221.780 107 169 150 104 138 68 123 99 75 134 165 448
2022/20231.779 180 156 70 207 254 202 110 158 227 18 111 86
2023/20241.279 90 121 90 37 92 227 74 109 38 49 44 308
2024/20254.834 112 123 405 256 487 459 281 306 861 388 632 524
2025/20268.435 1.427 835 2.202 1.576 1.824 571 0 0 0 0 0 0
Totale 27.813